ID Clinic Bangkok
| タイ | トルコ | オーストリア | |
| 幹細胞治療 | から $12,000 / 408,000฿ | から $12,000 / 408,000฿ | から $32,000 / 1,088,000฿ |
Bookimedは幹細胞治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックで幹細胞治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。幹細胞治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。幹細胞治療の旅路でお一人になることはありません。
Stem cell therapy for COPD in Thailand is safe in regulated facilities. This follows a 2026 ministerial decree classifying therapies as registered medicines. While clinics report better lung function, it remains an experimental treatment rather than a standard cure.
Bookimed Expert Insight: Thailand is a global hub with 150+ clinics. Only facilities like ID Clinic Bangkok maintain active Australian patient pathways. These clinics treat 4,000+ patients annually. Patients should choose clinics using mesenchymal cells with only 3–4 culture passages. This preserves the potency needed for respiratory conditions.
Patient Consensus: Many patients find these treatments more accessible than domestic options. However, they still view them as experimental. People often check cell source and count carefully to manage expectations for this therapy.
Specialised clinics in Bangkok and Phuket treat Chronic Obstructive Pulmonary Disease (COPD). They use mesenchymal stem cells (MSCs) to reduce lung inflammation. These therapies involve high-cell-count infusions, typically from 50 million to 100 million cells. They aim to improve breathing and reduce chronic coughing.
Bookimed Expert Insight: Thailand hosts over 150 clinics offering stem cell services. High-volume centres in Bangkok serve 4,000+ international patients annually. While some clinics use stem cells for aesthetic procedures, others provide 10-day intensive protocols. These protocols focus on lung regeneration and immune modulation.
Patient Consensus: Patients find Thailand geographically convenient. However, they emphasise the importance of checking cell manufacturing and laboratory testing transparency. Many report reduced coughing and improved energy levels after finishing their infusion protocols.
Stem cell treatment for COPD in Thailand aims to reduce lung inflammation and improve breathing using mesenchymal stem cells (MSCs). Most patients report better quality of life and increased stamina. They also see higher oxygen saturation levels rather than a complete cure.
Bookimed Expert Insight: Thailand is a global hub with 150+ clinics, but results depend on the disease stage. Data from clinics like ID Clinic Bangkok show the most consistent outcomes. This clinic treats 4,000+ patients annually, mostly those with moderate lung capacity.
Patient Consensus: Expect small but meaningful gains, such as walking further without gasping. Results vary between patients. Focus on functional improvements rather than expecting a total reversal.
Stem cell therapy for COPD introduces mesenchymal stem cells (MSCs) into the bloodstream. These cells help reduce airway inflammation and promote tissue repair. They migrate to damaged lung areas to slow disease progression and improve respiratory function. Clinics in Thailand typically use intravenous infusions to deliver cells safely.
Bookimed Expert Insight: Thailand is a major hub for regenerative medicine, with 154 clinics offering these therapies. Many patients seek treatment for emphysema. However, the most consistent results appear in those seeking an intensive anti-inflammatory boost. Success often depends on cell culture quality rather than just the total cell count.
Patient Consensus: Patients in Thailand often report improved energy and easier breathing shortly after the infusion. This approach works best to manage symptoms and slow progression rather than providing a permanent cure.
Mesenchymal Stem Cells (MSCs) are the most effective type for treating COPD. They target lung inflammation and are typically harvested from a patient's own fat tissue or bone marrow. This helps repair damaged air sacs and improves breathing capacity.
Bookimed Expert Insight: Thailand is a global hub for regenerative medicine with over 150 specialised clinics. Many Australian patients seek treatment for lung conditions there. Data shows Thailand serves over 2,000 international cases annually. It ranks third globally for these specialised respiratory requests.
Patient Consensus: Patients in Thailand often report improved breathing and better exercise tolerance. Many highlight the importance of choosing clinics that provide clear details on cell sourcing and testing.
The medical process for COPD stem cell treatment in Thailand takes 5–10 days in Bangkok. It involves remote record review and onsite lung function testing. Specialists use intravenous infusion of mesenchymal stem cells. They typically use umbilical cord-derived cells or adipose tissue to help repair lung structure. Doctors harvest this tissue via mini-liposuction.
Bookimed Expert Insight: Thailand has 154 clinics offering these therapies. Bangkok serves as the primary hub. Data shows high-dose protocols using 80–100 million cells often cost 40–50% more than standard infusions. Checking the passage number—how many times cells were cultured—helps confirm product quality before treatment begins.
Patient Consensus: Patients follow a direct-to-clinic pathway involving remote enquiries and onsite screenings in Thailand. Experience shows it is vital to confirm whether clinics use mesenchymal cells or exosomes for respiratory support.